LAURA PETERSEN to Veterans
This is a "connection" page, showing publications LAURA PETERSEN has written about Veterans.
Connection Strength
3.121
-
Contextual factors influencing the association between the Affordable Care Act's Medicaid expansion and Veteran VA-Medicaid dual enrollment. Health Serv Res. 2024 06; 59(3):e14280.
Score: 0.392
-
Determinants of referral network size for screening colonoscopies in the Veterans Health Administration after the implementation of the MISSION Act. Health Serv Res. 2024 02; 59(1):e14239.
Score: 0.383
-
Veterans Health Administration enrollees' choice of care setting relates to the expansion of care options: Evidence from screening colonoscopies before and after the MISSION Act. Health Serv Res. 2024 02; 59(1):e14241.
Score: 0.383
-
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. J Clin Lipidol. 2019 Sep - Oct; 13(5):797-803.e1.
Score: 0.288
-
Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans. Health Serv Res. 2010 Jun; 45(3):762-91.
Score: 0.151
-
Quality of depression care and its impact on health service use and mortality among veterans. Psychiatr Serv. 2008 Dec; 59(12):1399-405.
Score: 0.137
-
Use of smoking cessation interventions and aspirin for secondary prevention: are there racial disparities? Am J Med Qual. 2004 Jul-Aug; 19(4):166-71.
Score: 0.101
-
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
Score: 0.093
-
Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps. Ann Am Thorac Soc. 2023 04; 20(4):504-507.
Score: 0.093
-
Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis. Chest. 2023 08; 164(2):441-449.
Score: 0.092
-
Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res. 2003 Feb; 38(1 Pt 1):41-63.
Score: 0.092
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.086
-
Racial differences in health-related beliefs, attitudes, and experiences of VA cardiac patients: scale development and application. Med Care. 2002 Jan; 40(1 Suppl):I72-85.
Score: 0.085
-
Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care. 2002 Jan; 40(1 Suppl):I86-96.
Score: 0.085
-
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.
Score: 0.085
-
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839.
Score: 0.084
-
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther. 2022 04; 36(2):295-300.
Score: 0.080
-
Does the VA provide "primary" primary care? J Gen Intern Med. 1999 May; 14(5):318-9.
Score: 0.071
-
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration. J Gen Intern Med. 2018 08; 33(8):1276-1282.
Score: 0.066
-
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.058
-
Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol. 2011 Mar; 106(3):483-91.
Score: 0.039
-
VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care. 2009 Mar 16; 15(3):e1-8.
Score: 0.035
-
Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease. J Surg Res. 2008 Apr; 145(2):313-9.
Score: 0.032
-
Racial differences in how patients perceive physician communication regarding cardiac testing. Med Care. 2002 Jan; 40(1 Suppl):I27-34.
Score: 0.021
-
Comparison of use of medications after acute myocardial infarction in the Veterans Health Administration and Medicare. Circulation. 2001 Dec 11; 104(24):2898-904.
Score: 0.021
-
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 2022 02; 36(1):93-102.
Score: 0.020
-
Increasing use of Medicare services by veterans with acute myocardial infarction. Med Care. 1999 Jun; 37(6):529-37.
Score: 0.018
-
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240.
Score: 0.016
-
The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Ann Pharmacother. 2009 Oct; 43(10):1565-75.
Score: 0.009
-
Contribution of the Veterans Health Administration in understanding racial disparities in access and utilization of health care: a spirit of inquiry. Med Care. 2002 Jan; 40(1 Suppl):I3-13.
Score: 0.005